Cygenex Launches CyPHR AI-Powered Precision Health Assistant That Transforms DNA Into Real-Time Clinical Intelligence

United States, 25th Mar 2026 —Cygenex, a leader in precision medicine and pharmacogenomic risk optimization, today announced the launch of CyPHR (Cygenex Precision Health Response), an AI-powered health assistant designed to translate an individual’s genetic blueprint into actionable, real-time clinical guidance.

CyPHR represents a major advancement in the application of pharmacogenomics, bridging the gap between genetic insight and everyday healthcare decisions. By integrating DNA data with real-time health inputs, CyPHR delivers a 360-degree view of an individual’s health, empowering both patients and providers to move from reactive care to proactive, precision-driven intervention.

Eliminating Trial-and-Error Medicine

Traditional prescribing models rely heavily on trial and error, often resulting in ineffective therapies, adverse drug reactions, and avoidable healthcare costs.

CyPHR replaces this outdated approach with DNA-driven precision, analyzing how an individual’s genetic profile influences medication metabolism and response. By cross-referencing genetic data with current medications, CyPHR identifies potential risks, flags adverse interactions, and helps optimize medication selection and dosing.

“For decades, healthcare has operated without visibility into one of the most critical variables of individual biology,” said Charles Clark, CEO. “CyPHR changes that. It transforms static genetic data into a dynamic, real-time decision engine that improves outcomes while reducing unnecessary risk.”

A 24/7 Digital Health Co-Pilot

CyPHR functions as a continuous, AI-powered health companion providing users with ongoing guidance beyond the clinical setting. According to the product overview, CyPHR’s Precision Health Response assists with the following:

• Synthesizes genetic, lifestyle, and health data into clear, actionable insights
• Provides 24/7 personalized guidance between clinical visits
• Identifies potential risks early and supports preventive interventions
• Translates complex health information into simple, decision-ready recommendations

This enables individuals to take a more active role in their health, while helping providers deliver more targeted, effective care.

From Data to Daily Life

Unlike traditional genetic reports that remain static and underutilized, CyPHR converts DNA insights into a living, evolving health roadmap.

The platform continuously monitors health trends and aligns recommendations with each individual’s unique biology effectively serving as an AI-powered bridge between genetic data and real-world decision-making.

“CyPHR is not just about testing, it’s about translating genetic insight into daily action,” said Sharly Loggin, VP of Technology. “We are putting precision medicine directly into the hands of the individual.

Driving Measurable Health Impact

Early data highlights the potential of AI-driven, precision-guided care:

• Up to 95% reduction in error compared to manual health tracking
• Approximately 30% increase in adherence to healthier behaviors 

By improving medication alignment, enhancing adherence, and enabling earlier intervention, CyPHR addresses one of healthcare’s most significant challenges, inefficiency driven by a lack of personalization.

Enterprise-Grade Security

CyPHR is built on a secure, enterprise-grade infrastructure, ensuring that sensitive health and genetic data remains protected at all times and user data is:

• Stored within a secure environment on a major cloud platform
• Never exposed to the public internet
• Governed by strict enterprise-level security and privacy protocols

A New Standard for Precision Medicine

CyPHR represents a foundational step toward a future where healthcare is no longer reactive, but predictive where treatment decisions are informed by biology, not guesswork.

With CyPHR, Cygenex is redefining how genetic data is used, transforming it from a static report into a continuous, intelligent system that guides better health outcomes.

About Cygenex

Cygenex is a precision medicine company focused on identifying and mitigating medication-driven risk through advanced pharmacogenomics, AI-driven analytics, and population health optimization. By aligning medications to individual biology, Cygenex helps employers, TPAs, and stop-loss carriers reduce healthcare costs while improving clinical outcomes.

For More Product Information Contact:
Cygenex
Email: info@cygenex.com

https://cygenex.com 

Media Contact

Organization: Cygenex

Contact Person: Media Relations

Website: https://cygenex.com

Email: Send Email

Country:United States

Release id:43031

The post Cygenex Launches CyPHR AI-Powered Precision Health Assistant That Transforms DNA Into Real-Time Clinical Intelligence appeared first on King Newswire. This content is provided by a third-party source.. King Newswire is a press release distribution agency. We do not accept any responsibility or liability for the accuracy, content, images, videos, licences, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section above.